Factors Associated with the Severity of COVID-19 Symptoms among Leprosy Patients in Thailand
Keywords:
leprosy patients, factor associated, severity of COVID-19Abstract
Elderly, disabled, dependent, and chronically ill leprosy patients are vulnerable. When infected with
COVID-19, they will be more affected and severely affected than the general population. This study is
a cross-sectional study utilized retrospective data from the digital medical records system at Rajpracha
samasai Institute for the years 2020-2021. The objective was to investigate factors associated with the
severity of COVID-19 symptoms in leprosy patients in Thailand. The analysis method were descriptive
and inferential statistics, specifically multivariable logistic regression analysis. The study identified 120
leprosy patients who were infected by COVID-19; of whom 55.83% were male, with an average age
of 71 years. Among the participants, 80.83% had underlying conditions, 75.00% had deformities, and
57.50% were dependent on others. The factors that were significantly associated with the severity of
COVID-19 symptoms included male, employed, alcohol consumption, having underlying conditions,
abnormal chest X-ray findings, use of favipiravir combined with other medications, intravenous fluid
therapy combined with medication and abnormal blood concentration levels (p<0.05). After controlling
for inconsistent variables, and when controlling for the influence of confounding variables, it was found
that the X-ray results with abnormal lungs were a factor associated with the severity of COVID-19
symptoms in the leprosy patient group. Therefore, abnormal lung symptoms should be monitored by
annual X-ray examination to promote the quality of life of leprosy patients to live happily in their later
years according to individual differences.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Ministry of Public Health

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.